Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Infection
87%
Cytomegalovirus
56%
Cytomegalovirus Infection
35%
COVID-19
35%
Human Immunodeficiency Virus
34%
Transplantation
26%
Veterans Health
24%
Disease
20%
Drug Resistance
19%
Severe Acute Respiratory Syndrome Coronavirus 2
19%
Antivirus Agent
18%
Antibiotic Therapy
17%
Benzimidavir
16%
Hematopoietic Stem Cell Transplantation
16%
Antibiotics
16%
Ganciclovir
16%
Hematologic Malignancy
15%
Foscarnet
14%
Outpatient
14%
Gonorrhea
14%
Silo-Filler's Disease
13%
Clinical Trial
13%
DNA Polymerase
13%
Antiviral Resistance
12%
Human Cytomegalovirus
11%
Solid Organ Transplantation
11%
Bloodstream Infection
11%
Retrospective Cohort Study
11%
Antimicrobial Therapy
10%
Resistance Mutation
10%
Chlamydiae
10%
Diagnosis
10%
Cohort Effect
10%
Cohort Analysis
10%
Hematopoietic Stem Cell
9%
Endocarditis
9%
Antiinfective Agent
8%
Veterans Affairs
8%
Pseudomonas aeruginosa
8%
Carbapenem-Resistant Enterobacteriaceae
8%
Clinician
7%
Atypical Mycobacterium
7%
Symptom
7%
Infective Endocarditis
7%
Mycobacterium abscessus
7%
Prevalence
7%
Hepatitis B
7%
Substance Use Disorder
7%
Electronic Health Record
7%
Structural Gene
7%
Hepatitis B Virus
7%
Hepatitis C
7%
Antiviral Therapy
6%
Viremia
6%
Syphilis
6%
Drug Use
6%
Decision Making
6%
Methicillin Resistant Staphylococcus Aureus Infection
6%
Carbapenem
6%
Internal Medicine
6%
Virus Infection
6%
Infection Prevention
6%
Pathogen
6%
Bacterial Infection
5%
Phosphotransferase
5%
Hepatitis C Virus
5%
Carbapenemase
5%
Antibody Response
5%
Health Care
5%
Cell Culture
5%
Pre-Exposure Prophylaxis
5%
Immunology and Microbiology
Cytomegalovirus
100%
Human Cytomegalovirus
49%
COVID-19
34%
Transplant Procedure
31%
Codon
30%
Cytomegalovirus Infection
29%
Drug Resistance
22%
Severe Acute Respiratory Syndrome Coronavirus 2
18%
Human Immunodeficiency Virus
16%
Viral Load
16%
Vaccine Efficacy
15%
Hematopoietic Cell
15%
EC50
14%
Hematopoietic Stem Cell Transplantation
13%
DNA Polymerase
12%
Pseudomonas aeruginosa
12%
Infection
12%
Cell Culture
10%
IC50
10%
Viral Replication
10%
Gene Mutation
9%
Phenotype
9%
Vaccination Policy
9%
Recombinant Virus
9%
Glycoprotein
9%
Cross-Resistance
8%
Structural Gene
7%
Toxoplasmosis
7%
Solid Organ Transplantation
7%
Viremia
7%
Antibody Response
7%
Nontuberculous mycobacteria
7%
Amino Acid Substitution
7%
Methicillin-Resistant Staphylococcus Aureus
6%
Antiviral Activity
6%
Infectious Agent
6%
Dynamics
6%
Neutralizing Antibody
6%
Antiviral Resistance
6%
Staphylococcus Aureus
6%
T Cell
6%
Toxoplasma gondii
5%
Immune Response
5%
Neutralization
5%
Wild Type
5%
Genotype
5%
Polymerase Chain Reaction
5%
Stem Cell Transplant
5%
Viral Shedding
5%
Blood Plasma
5%
Titer
5%
Humoral Immunity
5%
Keyphrases
Cytomegalovirus
61%
UL97
29%
Veterans Health Administration
21%
Maribavir
21%
Cytomegalovirus Infection
20%
Haematopoietic Stem Cell Transplant Recipients
16%
Ganciclovir
15%
Pre-exposure Prophylaxis (PrEP)
13%
United States
13%
COVID-19
13%
Drug Resistance
12%
Confidence Interval
11%
Human Cytomegalovirus
11%
Risk Factors
11%
Oregon
11%
Foscarnet
11%
US Veterans
10%
Codon
10%
Cytomegalovirus Disease
10%
AIDS/HIV
9%
Ganciclovir Resistance
9%
Methicillin-resistant Staphylococcus Aureus
9%
Hospitalization
8%
Infection Rate
8%
UL97 Gene
8%
Men Who Have Sex with Men
8%
Infectious Diseases
7%
Retrospective Cohort Study
7%
Viral
7%
Virus
7%
Mycobacterium Tuberculosis (M. tb)
7%
Infection Prevention
7%
Drug Exposure
6%
Transplant Recipients
6%
Tuberculosis
6%
HIV Infection
6%
Outpatient Parenteral Antibiotic Therapy
6%
Antiviral Drug Resistance
6%
Carbapenem-resistant Enterobacteriaceae
6%
Thai
6%
Dalbavancin
6%
Infection Prophylaxis
6%
Hematopoietic Stem Cell Transplantation
6%
Chlamydia
6%
Odds Ratio
6%
Endocarditis
6%
Antibiotics
6%
Healthcare
6%
Gonorrhea
6%
UL54
5%
Antiretroviral Therapy
5%
Methicillin-resistant Staphylococcus Aureus Infection
5%
Antiviral Drugs
5%
Healthcare-associated
5%
Clinical Trials
5%
Drug Resistance mutations
5%
Multidisciplinary Team
5%
Multidrug Resistance
5%
Recombinant Virus
5%
Solid Organ Transplant Recipients
5%
Severe Disease
5%
Cidofovir
5%
HIV Pre-exposure Prophylaxis
5%